Steven D. Ertel, EVP & Chief Operating Officer at ACCELERON PHARMA INC (XLRN), sold 5,000 shares at $42.05 ($205K) on 2015-03-04, disclosed to the SEC on 2015-03-06.
Scheduled sale ($205k) by EVP & Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.54 | 2,557 | $104K | 50.6% |
| 2 | $41.28 | 2,043 | $84K | 41.2% |
| 3 | $42.05 | 400 | $17K | 8.2% |
| Total | $40.96 avg | 5,000 | $205K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |